We're working on profiling this company soon. Let us know you're interested by sending us a request here »
We're working hard to bring you this company's profile. Register here to get an alert as soon we're done.
In the meantime, if you are interested in participating in placements on this stock click "Follow" on the toolbar above.
ASX200 drops about 0.7pc on Wednesday Consumer Staples craters, as WOW CEO departs Small Caps led...
Read ArticleASX medical devices to make inroads with FDA after a good year for drug developers FDA is reviewing...
Read ArticleASX200 climbs a very laudable +0.85% Property stocks (+1.9%) and Health Care (+1.24%) have led the...
Read ArticleBenchmark ASX closes below 6,800 points All Sectors in red, but for IT Small caps led, in a very b...
Read ArticleNews relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD f...
Read ArticleL’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supr...
Read ArticleThe FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergenc...
Read ArticleGenetic Signatures jumps on FDA 510(k) application Allegra says FDA has questions related to its 51...
Read ArticleEarnings reports dominated headlines in August Despite solid results from ASX healthcare giants, th...
Read ArticleAustralian biotech has attracted US investments in the last five years Among ASX stocks to get fund...
Read ArticleBiotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two g...
Read ArticleThe end of pandemic and higher rates have subdued biotech market But there are signs now the sector...
Read ArticleBrisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “gam...
Read ArticleSmall cap health stocks are not known to pay dividends But there’s a handful of such stocks on the...
Read ArticleBiotech is making a comeback in 2023 There’s been a couple of breakthroughs on the ASX this year We...
Read ArticlePfizer said its diabetes drug works as well as Ozempic for weight loss What are the side effects of...
Read ArticleThe Federal Budget delivers billions of dollars funding into healthcare and aged care Mental health...
Read ArticleArtificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discove...
Read ArticleAllegra (AMT) submits a 501K application to the US Food and Drug Administration (FDA) for its Sr–HT–...
Read ArticleThe FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have g...
Read ArticleThe S&P ASX 200 rose 7.64%, in its best start to a year ever as global markets rally In a stron...
Read ArticleJapanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based devic...
Read ArticleASX health stocks have been out of favour this year with rotation away from growth to value sector...
Read ArticleWe take a look at how the 15 biotech IPOs that listed in 2021 are faring now Only two IPO stocks fr...
Read ArticleASX 200 gains 1% Small Caps index does the same, but then gives it all back ODE wins and NIC MD Ju...
Read ArticleASX 200 ends 1.4% lower Emerging Co’s index sheds 0.7% I knew IRIS Metals would do well today The...
Read ArticleStockhead’s Top 10 at 10, published at 10.30am each trading day, highlights the best (and worst) per...
Read ArticleUS FDA approves the first clinical trial using naturally derived psychedelic drugs It could open po...
Read ArticleA recent research reveals which biotech segments VCs are ploughing billions of dollars into We list...
Read ArticleThe Healthcare sector has been struggling as the pandemic wanes But most money managers are still b...
Read ArticleThe healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak mark...
Read ArticleBiotech sector has had a tough time recently But there are signs of things improving this year A lo...
Read ArticleTelehealth was already a growing space even before the pandemic, but COVID had launched it into the...
Read ArticleThe ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial t...
Read ArticleIG Markets’ Kyle Rodda says a surging iron ore price – which topped $150 per tonne again overnight –...
Read ArticleThe S&P/ASX200 climbed into the close on Tuesday. Most of the 35 or so point gain (0.5%) comes...
Read ArticleThings weren’t looking good ahead of the opening bell today, after a rough session for US stocks fol...
Read ArticleOuch. The ASX has closed the third trading day of the year with a melt down of 2.74%. The Australia...
Read ArticleAt the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, be...
Read ArticleIt’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 los...
Read ArticleIt’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 los...
Read ArticleHighlights Many ASX stocks have surged over 35% during the last three months. A powerful moment...
Read ArticleThe ASX finished September on a solid note but not enough to avoid the worst month since March 2020....
Read ArticleThe ASX was set for another negative day if futures and Wall Street’s drop were any guide — but even...
Read ArticleAlthough earnings results were the main theme in August, there were also some notable healthcare bre...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 7...
Read ArticleSummary Nutritional Growth Solutions has entered into a non-exclusive supply agreement to launch...
Read ArticleThe ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 7...
Read ArticleIt’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52...
Read ArticleEach week, Stockhead recaps ASX stocks that are “running hot” as deduced by the Relative Strength In...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has ret...
Read ArticleInvestors will be watching for updates on Traka Resources (ASX:TKL) this week, after the gold explor...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleThe ASX finished up today and every sector gained…except resources. The ASX 200 gained 0.44 per cent...
Read ArticleWall Street sets record highs again on Friday as Bitcoin tumbles The Dow Jones and S&P 500 close...
Read ArticleClosing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at th...
Read ArticleSource: Monster Ztudio, Shutterstock Summary Allegra Orthopaedics has reported completing the 8...
Read ArticleStockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) per...
Read ArticleHere’s our fortnightly wrap of all the news driving ASX health stocks. It’s been a mixed two weeks f...
Read ArticleThe Allegra Orthopaedics Ltd (ASX: AMT) share price lifted 6.45% today, finishing the trading sessi...
Read ArticleThe Allegra Orthopaedics Ltd (ASX: AMT) share price is surging today as investors are fighting to s...
Read ArticleAllegra Orthopaedics (ASX:AMT) shares climbed today after another impressive round of positive resul...
Read ArticleThe company is progressing with the new spinal cage design and plans to commence a pilot animal stud...
Read ArticleThe Allegra Orthopaedics Ltd (ASX: AMT) share price shot up 137.5% today on positive test results....
Read ArticleSummary Allegra Orthopaedics announced promising results on its Spinal Cage Device flagship inno...
Read ArticleA quick wrap of the ASX’s key winners and losers on Friday, September 4. Data is taken after the mar...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleA quick wrap of the ASX’s key winners and losers on Monday, July 20. Data is taken after the market...
Read ArticleHealthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financia...
Read ArticleA quick wrap of the ASX’s key winners and losers on Wednesday, July 8. Data is taken after the marke...
Read ArticleA quick wrap of the ASX’s key winners and losers on Tuesday, July 7. Data is taken after the market...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleOn Monday, the Allegra Orthopaedics Ltd (ASX: AMT) share price soared 502.27% as it announced the a...
Read ArticleAfter six years of collaborating with the University of Sydney on a synthetic bone substitute, Alleg...
Read ArticleA quick wrap of the key winners and losers on Monday, July 6. Data is taken after the market closes...
Read ArticleA quick wrap of the key winners and losers on Friday, June 12. Data is taken after the market closes...
Read ArticleAs a result of the severe and mounting disruption to the supply of personal protective equipment (PP...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleYou don’t need a PhD to run a biotech, but sometimes it helps, as these companies deal in one of the...
Read ArticleHealth care in Australia is the most diversified and dynamic sector and has the potential to generat...
Read ArticleStockhead’s Top 10 at 10 highlights the best (and worst) performing ASX small caps in morning trade....
Read ArticleHere’s our fortnightly wrap of the major small cap health stock winners and losers. One small cap A...
Read ArticleMedical devices are one of an essential parts of health care system. These are used for accurate dia...
Read Article
Open an account with an online broker of your choice. If you do not have an existing broker, consider Vested Equities' A$9.50 flat fee platform.
Sign up now »Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.
